Kaico Ltd.

Japon

Retour au propriétaire

1-13 de 13 pour Kaico Ltd. Trier par
Recheche Texte
Affiner par
Type PI
        Marque 8
        Brevet 5
Juridiction
        International 6
        Canada 4
        États-Unis 3
Date
2024 4
2023 6
2022 2
2020 1
Classe IPC
A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps 4
A61P 37/04 - Immunostimulants 4
A61K 39/12 - Antigènes viraux 3
C12N 15/34 - Protéines de virus à ADN 3
C12N 15/866 - Vecteurs baculoviraux 3
Voir plus
Classe NICE
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser. 8
05 - Produits pharmaceutiques, vétérinaires et hygièniques 8
42 - Services scientifiques, technologiques et industriels, recherche et conception 5
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture. 5
Statut
En Instance 6
Enregistré / En vigueur 7

1.

ORAL VACCINE COMPOSITION

      
Numéro d'application 18285970
Statut En instance
Date de dépôt 2022-04-08
Date de la première publication 2024-06-06
Propriétaire
  • KAICO LTD. (Japon)
  • KAGOSHIMA UNIVERSITY (Japon)
  • KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (Japon)
Inventeur(s)
  • Yamato, Kenta
  • Miyata, Takeshi
  • Kusakabe, Takahiro
  • Lee, Jae Man
  • Masuda, Akitsu

Abrégé

A method of easily producing an immunogenic pupa for oral administration and a pupa for oral administration produced by the method are provided. The method is a method of producing a pupa for oral administration, including a step of infecting a larva or pupa of an insect capable of being baculovirus-infected with a recombinant baculovirus having DNA encoding an antigen protein introduced therein and freeze-drying a pupa having pupated from the infected larva or the infected pupa.

Classes IPC  ?

2.

Miscellaneous Design

      
Numéro d'application 1772864
Statut Enregistrée
Date de dépôt 2023-12-08
Date d'enregistrement 2023-12-08
Propriétaire KAICO LTD. (Japon)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; soaps; detergents for household use; shampoos; non-medicated pet shampoos; non-medicated toiletry preparations. Pharmaceutical preparations; protein and amino acid preparations; medicines for human purposes; medicines for veterinary purposes; vaccines; human vaccine preparations; veterinary vaccines; chemical reagents for medical or veterinary purposes; reagents for medical use; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; nutritional additives to foodstuffs for animals, for medical purposes; dietetic animal foodstuffs for medical purposes; dietary supplements for animal; fodder additives for medical purposes; protein supplements for animals; medicated toiletry preparations.

3.

KAICO

      
Numéro d'application 1772899
Statut Enregistrée
Date de dépôt 2023-12-08
Date d'enregistrement 2023-12-08
Propriétaire KAICO LTD. (Japon)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; non-medicated cosmetics; non-medicated dentifrices. Pharmaceutical preparations; protein and amino acid preparations; medicines for human purposes; medicines for veterinary purposes; vaccines; human vaccine preparations; veterinary vaccines; chemical reagents for medical or veterinary purposes; reagents for medical use; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; nutritional additives to foodstuffs for animals, for medical purposes; dietetic animal foodstuffs for medical purposes; dietary supplements for animal; fodder additives for medical purposes; protein supplements for animals; medicated toiletry preparations. Medical research; biomedical research services; cosmetics research; vaccine research and development services; research services in the field of proteins, antibodies, microorganisms and cells; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; research and development services in the field of protein expression systems. Medical analysis for the diagnosis and treatment of persons; advisory services relating to health; provision of health information; medical examination services; health assessment services; medical consultations; medical information; medical examination services for antibody testing.

4.

KAICO LTD.

      
Numéro d'application 1771574
Statut Enregistrée
Date de dépôt 2023-12-08
Date d'enregistrement 2023-12-08
Propriétaire KAICO LTD. (Japon)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; soaps; detergents for household use; shampoos; non-medicated pet shampoos; non-medicated toiletry preparations. Pharmaceutical preparations; protein and amino acid preparations; medicines for human purposes; medicines for veterinary purposes; vaccines; human vaccine preparations; veterinary vaccines; chemical reagents for medical or veterinary purposes; reagents for medical use; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; nutritional additives to foodstuffs for animals, for medical purposes; dietetic animal foodstuffs for medical purposes; dietary supplements for animal; fodder additives for medical purposes; protein supplements for animals; medicated toiletry preparations. Medical research; biomedical research services; cosmetics research; vaccine research and development services; research services in the field of proteins, antibodies, microorganisms and cells; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; research and development services in the field of protein expression systems. Medical analysis for the diagnosis and treatment of persons; advisory services relating to health; provision of health information; medical examination services; health assessment services; medical consultations; medical information; medical examination services for antibody testing.

5.

STYLIZED LEAF DESIGN

      
Numéro d'application 230686900
Statut En instance
Date de dépôt 2023-12-08
Propriétaire KAICO LTD. (Japon)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; soaps; detergents for household use; shampoos; non-medicated pet shampoos; non-medicated toiletry preparations. (2) Pharmaceutical preparations; protein and amino acid preparations; medicines for human purposes; medicines for veterinary purposes; vaccines; human vaccine preparations; veterinary vaccines; chemical reagents for medical or veterinary purposes; reagents for medical use; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; nutritional additives to foodstuffs for animals, for medical purposes; dietetic animal foodstuffs for medical purposes; dietary supplements for animal; fodder additives for medical purposes; protein supplements for animals; medicated toiletry preparations.

6.

Miscellaneous Design

      
Numéro de série 79388001
Statut Enregistrée
Date de dépôt 2023-12-08
Date d'enregistrement 2025-01-28
Propriétaire KAICO LTD. (Japon)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; bath soaps, non-medicated hand soap, perfumed soap, bar soap; detergents for household use; shampoos; non-medicated pet shampoos; non-medicated toiletry preparations Pharmaceutical preparations for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi; vaccines for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi; protein and amino acid preparations for medical purposes; medicines for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi, for human purposes; medicines for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi, for veterinary purposes; vaccines; human vaccine preparations; veterinary vaccines; chemical reagents for medical or veterinary purposes; reagents for medical use; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; animal feed additive for use as a nutritional supplement for medical purposes; dietetic animal foodstuffs for medical purposes; animal fodder additives in the nature of fodder proteins, including those derived from silkworms, for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi, for medical purposes; protein supplements for animals; medicated toiletry preparations

7.

KAICO

      
Numéro de série 79388010
Statut En instance
Date de dépôt 2023-12-08
Propriétaire KAICO LTD. (Japon)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; non-medicated cosmetics; non-medicated dentifrices; all utilizing proteins derived from silkworms Pharmaceutical preparations for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi; vaccines for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi; protein and amino acid preparations for medical purposes; medicines for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi, for human purposes; medicines for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi, for veterinary purposes; vaccines; human vaccine preparations; veterinary vaccines; chemical reagents for medical or veterinary purposes; reagents for medical use; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; animal feed additive for use as a nutritional supplement for medical purposes; dietetic animal foodstuffs for medical purposes; animal fodder additives in the nature of fodder proteins, including those derived from silkworms, for the acquisition of immunity against viruses, bacteria, and fungi, prevention of infection related to viruses, bacteria, and fungi, and prevention of disease onset caused by viruses, bacteria, and fungi, for medical purpose; protein supplements for animals; medicated toiletry preparations; all utilizing proteins derived from silkworms Medical research; biomedical research services; cosmetics research; vaccine research and development services; research services in the field of proteins, antibodies, microorganisms and cells; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; research and development services in the field of protein expression systems; all related to proteins derived from silkworms Medical analysis for the diagnosis and treatment of persons; advisory services relating to health; provision of health information; medical examination services; health assessment services; medical consultations; medical information; medical examination services for antibody testing; all related to proteins derived from silkworms

8.

KAICO LTD.

      
Numéro d'application 230565600
Statut En instance
Date de dépôt 2023-12-08
Propriétaire KAICO LTD. (Japon)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; soaps; detergents for household use; shampoos; non-medicated pet shampoos; non-medicated toiletry preparations. (2) Pharmaceutical preparations; protein and amino acid preparations; medicines for human purposes; medicines for veterinary purposes; vaccines; human vaccine preparations; veterinary vaccines; chemical reagents for medical or veterinary purposes; reagents for medical use; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; nutritional additives to foodstuffs for animals, for medical purposes; dietetic animal foodstuffs for medical purposes; dietary supplements for animal; fodder additives for medical purposes; protein supplements for animals; medicated toiletry preparations. (1) Medical research; biomedical research services; cosmetics research; vaccine research and development services; research services in the field of proteins, antibodies, microorganisms and cells; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; research and development services in the field of protein expression systems. (2) Medical analysis for the diagnosis and treatment of persons; advisory services relating to health; provision of health information; medical examination services; health assessment services; medical consultations; medical information; medical examination services for antibody testing.

9.

KAICO

      
Numéro d'application 230686800
Statut En instance
Date de dépôt 2023-12-08
Propriétaire KAICO LTD. (Japon)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Cosmetics; beauty care cosmetics; hand creams; cosmetics for animals; non-medicated cosmetics; non-medicated dentifrices. (2) Pharmaceutical preparations; protein and amino acid preparations; medicines for human purposes; medicines for veterinary purposes; vaccines; human vaccine preparations; veterinary vaccines; chemical reagents for medical or veterinary purposes; reagents for medical use; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; nutritional additives to foodstuffs for animals, for medical purposes; dietetic animal foodstuffs for medical purposes; dietary supplements for animal; fodder additives for medical purposes; protein supplements for animals; medicated toiletry preparations. (1) Medical research; biomedical research services; cosmetics research; vaccine research and development services; research services in the field of proteins, antibodies, microorganisms and cells; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; research and development services in the field of protein expression systems. (2) Medical analysis for the diagnosis and treatment of persons; advisory services relating to health; provision of health information; medical examination services; health assessment services; medical consultations; medical information; medical examination services for antibody testing.

10.

ORAL VACCINE COMPOSITION

      
Numéro d'application JP2023020590
Numéro de publication 2023/234407
Statut Délivré - en vigueur
Date de dépôt 2023-06-02
Date de publication 2023-12-07
Propriétaire
  • KAICO LTD. (Japon)
  • KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (Japon)
Inventeur(s)
  • Yamato Kenta
  • Taniguchi Masahiro
  • Nakatake Hirokazu
  • Esaki Keiichi
  • Kusakabe Takahiro

Abrégé

An oral vaccine composition against a porcine circovirus-related disease, the oral vaccine composition comprising a pupa or a cell of a baculovirus infectious insect that has been subjected to an infection treatment with a recombinant baculovirus into which a DNA encoding a porcine circovirus type 2 protein has been introduced and subjected to a freeze-drying treatment.

Classes IPC  ?

  • A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
  • A61K 39/39 - Préparations médicinales contenant des antigènes ou des anticorps caractérisées par les additifs immunostimulants, p. ex. par les adjuvants chimiques
  • A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
  • A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire
  • A61P 13/12 - Médicaments pour le traitement des troubles du système urinaire des reins
  • A61P 31/20 - Antiviraux pour le traitement des virus ADN
  • A61P 37/04 - Immunostimulants
  • A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
  • A61K 9/19 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres lyophilisées
  • C12N 7/01 - Virus, p. ex. bactériophages, modifiés par l'introduction de matériel génétique étranger
  • C12N 15/34 - Protéines de virus à ADN
  • C12N 15/86 - Vecteurs viraux
  • C12N 15/866 - Vecteurs baculoviraux
  • A61K 38/02 - Peptides à nombre indéterminé d'amino-acidesLeurs dérivés
  • A61K 35/64 - Insectes, p. ex. abeilles, guêpes ou puces

11.

ORAL VACCINE COMPOSITION

      
Numéro d'application JP2022017328
Numéro de publication 2022/215742
Statut Délivré - en vigueur
Date de dépôt 2022-04-08
Date de publication 2022-10-13
Propriétaire
  • KAICO LTD. (Japon)
  • KAGOSHIMA UNIVERSITY (Japon)
  • KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (Japon)
Inventeur(s)
  • Yamato Kenta
  • Miyata Takeshi
  • Kusakabe Takahiro
  • Lee Jae Man
  • Masuda Akitsu

Abrégé

[Problem] To provide: a method for simply producing an immunogenic chrysalis for oral administration; and a chrysalis which is for oral administration and produced by said method. [Solution] This method for producing a chrysalis for oral use comprises a step for infecting a larva or chrysalis of a baculovirus infectious insect with a recombinant baculovirus, into which DNA encoding an antigen protein has been introduced, and freeze-drying a chrysalis pupated from the infected larva or the infected chrysalis.

Classes IPC  ?

  • A01K 67/033 - NÉCESSITÉS COURANTES DE LA VIE ÉLEVAGE; CHASSE; PIÉGEAGE; PÊCHE ÉLEVAGE; AVICULTURE; APICULTURE; PISCICULTURE; PÊCHE; OBTENTION D'ANIMAUX, NON PRÉVUE AILLEURS; NOUVELLES RACES D'ANIMAUX Élevage ou obtention d'animaux, non prévus ailleurs; Nouvelles races d'animaux Élevage ou obtention d'invertébrés; Nouvelles races d'invertébrés
  • A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
  • A61K 35/12 - Substances provenant de mammifèresCompositions comprenant des tissus ou des cellules non spécifiésCompositions comprenant des cellules souches non embryonnairesCellules génétiquement modifiées
  • A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
  • A61K 39/12 - Antigènes viraux
  • A61P 37/04 - Immunostimulants
  • C12N 5/10 - Cellules modifiées par l'introduction de matériel génétique étranger, p. ex. cellules transformées par des virus
  • C12N 15/34 - Protéines de virus à ADN
  • C12N 15/40 - Protéines de virus à ARN, p. ex. flavivirus
  • C12N 15/866 - Vecteurs baculoviraux

12.

ORAL VACCINE COMPOSITION

      
Numéro de document 03216205
Statut En instance
Date de dépôt 2022-04-08
Date de disponibilité au public 2022-10-13
Propriétaire
  • KAGOSHIMA UNIVERSITY (Japon)
  • KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (Japon)
  • KAICO LTD. (Japon)
Inventeur(s)
  • Yamato, Kenta
  • Miyata, Takeshi
  • Kusakabe, Takahiro
  • Lee, Jae Man
  • Masuda, Akitsu

Abrégé

[Problem] To provide: a method for simply producing an immunogenic chrysalis for oral administration; and a chrysalis which is for oral administration and produced by said method. [Solution] This method for producing a chrysalis for oral use comprises a step for infecting a larva or chrysalis of a baculovirus infectious insect with a recombinant baculovirus, into which DNA encoding an antigen protein has been introduced, and freeze-drying a chrysalis pupated from the infected larva or the infected chrysalis.

Classes IPC  ?

  • A01K 67/033 - NÉCESSITÉS COURANTES DE LA VIE ÉLEVAGE; CHASSE; PIÉGEAGE; PÊCHE ÉLEVAGE; AVICULTURE; APICULTURE; PISCICULTURE; PÊCHE; OBTENTION D'ANIMAUX, NON PRÉVUE AILLEURS; NOUVELLES RACES D'ANIMAUX Élevage ou obtention d'animaux, non prévus ailleurs; Nouvelles races d'animaux Élevage ou obtention d'invertébrés; Nouvelles races d'invertébrés
  • A23L 33/10 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs
  • A61K 35/12 - Substances provenant de mammifèresCompositions comprenant des tissus ou des cellules non spécifiésCompositions comprenant des cellules souches non embryonnairesCellules génétiquement modifiées
  • A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
  • A61K 39/12 - Antigènes viraux
  • A61P 37/04 - Immunostimulants
  • C12N 5/10 - Cellules modifiées par l'introduction de matériel génétique étranger, p. ex. cellules transformées par des virus
  • C12N 15/34 - Protéines de virus à ADN
  • C12N 15/40 - Protéines de virus à ARN, p. ex. flavivirus
  • C12N 15/866 - Vecteurs baculoviraux

13.

BABESIA PROTOZOA, AND DIAGNOSTIC METHOD FOR BABESIOSIS

      
Numéro d'application JP2019008255
Numéro de publication 2020/174690
Statut Délivré - en vigueur
Date de dépôt 2019-02-25
Date de publication 2020-09-03
Propriétaire KAICO LTD. (Japon)
Inventeur(s)
  • Kusakabe, Takahiro
  • Arakawa, Takeshi
  • Tamaki, Yukihiro
  • Tsuji, Naotoshi

Abrégé

BabesiaBabesia protozoa, the amino acid sequence of the N-terminal signal peptide thereof and the amino acid sequence of the region from a transmembrane region to the C-terminus thereof; and a detection or diagnostic method for Babesiosis using the protein.

Classes IPC  ?

  • C07K 14/44 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de protozoaires
  • A61K 39/018 - Antigènes de Babesia, p. ex. antigènes de Theileria
  • A61P 33/02 - Antiprotozoaires, p. ex. pour le traitement de la leishmaniose, de la trichomonase, de la toxoplasmose
  • C12N 5/07 - Cellules animales ou tissus animaux
  • C12N 15/63 - Introduction de matériel génétique étranger utilisant des vecteursVecteurs Utilisation d'hôtes pour ceux-ciRégulation de l'expression
  • G01N 33/53 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet